The global market for Kidney Cancer Treatment Drugs was valued at US$ 5458 million in the year 2024 and is projected to reach a revised size of US$ 6842 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Kidney Cancer Treatment Drugs Market

Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Treatment Drugs.

The Kidney Cancer Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Cancer Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Kidney Cancer Treatment Drugs Market Report

Report Metric	Details
Report Name	Kidney Cancer Treatment Drugs Market
Accounted market size in year	US$ 5458 million
Forecasted market size in 2031	US$ 6842 million
CAGR	3.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Angiogenesis Inhibitors mTOR Inhibitors Monoclonal Antibodies Cytokine Immunotherapy (IL-2)
Segment by Application	Hospitals Research Institutes Diagnostic Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amgen/Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck, Roche, Pfizer, Bristol-Myers Squibb, Eisai, Prometheus Labs, Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kidney Cancer Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Kidney Cancer Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Kidney Cancer Treatment Drugs Market growing?

Ans: The Kidney Cancer Treatment Drugs Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Kidney Cancer Treatment Drugs Market size in 2031?

Ans: The Kidney Cancer Treatment Drugs Market size in 2031 will be US$ 6842 million.

Who are the main players in the Kidney Cancer Treatment Drugs Market report?

Ans: The main players in the Kidney Cancer Treatment Drugs Market are Amgen/Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck, Roche, Pfizer, Bristol-Myers Squibb, Eisai, Prometheus Labs, Novartis

What are the Application segmentation covered in the Kidney Cancer Treatment Drugs Market report?

Ans: The Applications covered in the Kidney Cancer Treatment Drugs Market report are Hospitals, Research Institutes, Diagnostic Centers, Others

What are the Type segmentation covered in the Kidney Cancer Treatment Drugs Market report?

Ans: The Types covered in the Kidney Cancer Treatment Drugs Market report are Angiogenesis Inhibitors, mTOR Inhibitors, Monoclonal Antibodies, Cytokine Immunotherapy (IL-2)

1 Kidney Cancer Treatment Drugs Market Overview

1.1 Product Definition

1.2 Kidney Cancer Treatment Drugs by Type

1.2.1 Global Kidney Cancer Treatment Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Angiogenesis Inhibitors

1.2.3 mTOR Inhibitors

1.2.4 Monoclonal Antibodies

1.2.5 Cytokine Immunotherapy (IL-2)

1.3 Kidney Cancer Treatment Drugs by Application

1.3.1 Global Kidney Cancer Treatment Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Research Institutes

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Global Kidney Cancer Treatment Drugs Market Size Estimates and Forecasts

1.4.1 Global Kidney Cancer Treatment Drugs Revenue 2020-2031

1.4.2 Global Kidney Cancer Treatment Drugs Sales 2020-2031

1.4.3 Global Kidney Cancer Treatment Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Kidney Cancer Treatment Drugs Market Competition by Manufacturers

2.1 Global Kidney Cancer Treatment Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Kidney Cancer Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Kidney Cancer Treatment Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Kidney Cancer Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Kidney Cancer Treatment Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Kidney Cancer Treatment Drugs, Product Type & Application

2.7 Global Key Manufacturers of Kidney Cancer Treatment Drugs, Date of Enter into This Industry

2.8 Global Kidney Cancer Treatment Drugs Market Competitive Situation and Trends

2.8.1 Global Kidney Cancer Treatment Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Kidney Cancer Treatment Drugs Players Market Share by Revenue

2.8.3 Global Kidney Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Kidney Cancer Treatment Drugs Market Scenario by Region

3.1 Global Kidney Cancer Treatment Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Kidney Cancer Treatment Drugs Sales by Region: 2020-2031

3.2.1 Global Kidney Cancer Treatment Drugs Sales by Region: 2020-2025

3.2.2 Global Kidney Cancer Treatment Drugs Sales by Region: 2026-2031

3.3 Global Kidney Cancer Treatment Drugs Revenue by Region: 2020-2031

3.3.1 Global Kidney Cancer Treatment Drugs Revenue by Region: 2020-2025

3.3.2 Global Kidney Cancer Treatment Drugs Revenue by Region: 2026-2031

3.4 North America Kidney Cancer Treatment Drugs Market Facts & Figures by Country

3.4.1 North America Kidney Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Kidney Cancer Treatment Drugs Sales by Country (2020-2031)

3.4.3 North America Kidney Cancer Treatment Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Kidney Cancer Treatment Drugs Market Facts & Figures by Country

3.5.1 Europe Kidney Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Kidney Cancer Treatment Drugs Sales by Country (2020-2031)

3.5.3 Europe Kidney Cancer Treatment Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Kidney Cancer Treatment Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Kidney Cancer Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Kidney Cancer Treatment Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Kidney Cancer Treatment Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Kidney Cancer Treatment Drugs Market Facts & Figures by Country

3.7.1 Latin America Kidney Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Kidney Cancer Treatment Drugs Sales by Country (2020-2031)

3.7.3 Latin America Kidney Cancer Treatment Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Kidney Cancer Treatment Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Kidney Cancer Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Kidney Cancer Treatment Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Kidney Cancer Treatment Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Kidney Cancer Treatment Drugs Sales by Type (2020-2031)

4.1.1 Global Kidney Cancer Treatment Drugs Sales by Type (2020-2025)

4.1.2 Global Kidney Cancer Treatment Drugs Sales by Type (2026-2031)

4.1.3 Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2020-2031)

4.2 Global Kidney Cancer Treatment Drugs Revenue by Type (2020-2031)

4.2.1 Global Kidney Cancer Treatment Drugs Revenue by Type (2020-2025)

4.2.2 Global Kidney Cancer Treatment Drugs Revenue by Type (2026-2031)

4.2.3 Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Kidney Cancer Treatment Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Kidney Cancer Treatment Drugs Sales by Application (2020-2031)

5.1.1 Global Kidney Cancer Treatment Drugs Sales by Application (2020-2025)

5.1.2 Global Kidney Cancer Treatment Drugs Sales by Application (2026-2031)

5.1.3 Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2020-2031)

5.2 Global Kidney Cancer Treatment Drugs Revenue by Application (2020-2031)

5.2.1 Global Kidney Cancer Treatment Drugs Revenue by Application (2020-2025)

5.2.2 Global Kidney Cancer Treatment Drugs Revenue by Application (2026-2031)

5.2.3 Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Kidney Cancer Treatment Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Amgen/Allergan

6.1.1 Amgen/Allergan Company Information

6.1.2 Amgen/Allergan Description and Business Overview

6.1.3 Amgen/Allergan Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Amgen/Allergan Kidney Cancer Treatment Drugs Product Portfolio

6.1.5 Amgen/Allergan Recent Developments/Updates

6.2 Argos Therapeutics

6.2.1 Argos Therapeutics Company Information

6.2.2 Argos Therapeutics Description and Business Overview

6.2.3 Argos Therapeutics Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Argos Therapeutics Kidney Cancer Treatment Drugs Product Portfolio

6.2.5 Argos Therapeutics Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AstraZeneca Kidney Cancer Treatment Drugs Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Aveo Pharmaceuticals

6.4.1 Aveo Pharmaceuticals Company Information

6.4.2 Aveo Pharmaceuticals Description and Business Overview

6.4.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product Portfolio

6.4.5 Aveo Pharmaceuticals Recent Developments/Updates

6.5 Bayer

6.5.1 Bayer Company Information

6.5.2 Bayer Description and Business Overview

6.5.3 Bayer Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Bayer Kidney Cancer Treatment Drugs Product Portfolio

6.5.5 Bayer Recent Developments/Updates

6.6 Exelixis

6.6.1 Exelixis Company Information

6.6.2 Exelixis Description and Business Overview

6.6.3 Exelixis Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Exelixis Kidney Cancer Treatment Drugs Product Portfolio

6.6.5 Exelixis Recent Developments/Updates

6.7 Incyte

6.7.1 Incyte Company Information

6.7.2 Incyte Description and Business Overview

6.7.3 Incyte Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Incyte Kidney Cancer Treatment Drugs Product Portfolio

6.7.5 Incyte Recent Developments/Updates

6.8 Merck

6.8.1 Merck Company Information

6.8.2 Merck Description and Business Overview

6.8.3 Merck Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Merck Kidney Cancer Treatment Drugs Product Portfolio

6.8.5 Merck Recent Developments/Updates

6.9 Roche

6.9.1 Roche Company Information

6.9.2 Roche Description and Business Overview

6.9.3 Roche Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Roche Kidney Cancer Treatment Drugs Product Portfolio

6.9.5 Roche Recent Developments/Updates

6.10 Pfizer

6.10.1 Pfizer Company Information

6.10.2 Pfizer Description and Business Overview

6.10.3 Pfizer Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Pfizer Kidney Cancer Treatment Drugs Product Portfolio

6.10.5 Pfizer Recent Developments/Updates

6.11 Bristol-Myers Squibb

6.11.1 Bristol-Myers Squibb Company Information

6.11.2 Bristol-Myers Squibb Description and Business Overview

6.11.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product Portfolio

6.11.5 Bristol-Myers Squibb Recent Developments/Updates

6.12 Eisai

6.12.1 Eisai Company Information

6.12.2 Eisai Description and Business Overview

6.12.3 Eisai Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Eisai Kidney Cancer Treatment Drugs Product Portfolio

6.12.5 Eisai Recent Developments/Updates

6.13 Prometheus Labs

6.13.1 Prometheus Labs Company Information

6.13.2 Prometheus Labs Description and Business Overview

6.13.3 Prometheus Labs Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Prometheus Labs Kidney Cancer Treatment Drugs Product Portfolio

6.13.5 Prometheus Labs Recent Developments/Updates

6.14 Novartis

6.14.1 Novartis Company Information

6.14.2 Novartis Description and Business Overview

6.14.3 Novartis Kidney Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Novartis Kidney Cancer Treatment Drugs Product Portfolio

6.14.5 Novartis Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Kidney Cancer Treatment Drugs Industry Chain Analysis

7.2 Kidney Cancer Treatment Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Kidney Cancer Treatment Drugs Production Mode & Process Analysis

7.4 Kidney Cancer Treatment Drugs Sales and Marketing

7.4.1 Kidney Cancer Treatment Drugs Sales Channels

7.4.2 Kidney Cancer Treatment Drugs Distributors

7.5 Kidney Cancer Treatment Drugs Customer Analysis

8 Kidney Cancer Treatment Drugs Market Dynamics

8.1 Kidney Cancer Treatment Drugs Industry Trends

8.2 Kidney Cancer Treatment Drugs Market Drivers

8.3 Kidney Cancer Treatment Drugs Market Challenges

8.4 Kidney Cancer Treatment Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Kidney Cancer Treatment Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Kidney Cancer Treatment Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Kidney Cancer Treatment Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Kidney Cancer Treatment Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Kidney Cancer Treatment Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Kidney Cancer Treatment Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Kidney Cancer Treatment Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Kidney Cancer Treatment Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Kidney Cancer Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Kidney Cancer Treatment Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Kidney Cancer Treatment Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Kidney Cancer Treatment Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Kidney Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Treatment Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Kidney Cancer Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Kidney Cancer Treatment Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Kidney Cancer Treatment Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Kidney Cancer Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Kidney Cancer Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Kidney Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Kidney Cancer Treatment Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Kidney Cancer Treatment Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Kidney Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Kidney Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Kidney Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Kidney Cancer Treatment Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Kidney Cancer Treatment Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Kidney Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Kidney Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Kidney Cancer Treatment Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Kidney Cancer Treatment Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Kidney Cancer Treatment Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Kidney Cancer Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Kidney Cancer Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Kidney Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Kidney Cancer Treatment Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Kidney Cancer Treatment Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Kidney Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Kidney Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Kidney Cancer Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Kidney Cancer Treatment Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Kidney Cancer Treatment Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Kidney Cancer Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Kidney Cancer Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Kidney Cancer Treatment Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Kidney Cancer Treatment Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Kidney Cancer Treatment Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Kidney Cancer Treatment Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Kidney Cancer Treatment Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Kidney Cancer Treatment Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Kidney Cancer Treatment Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Kidney Cancer Treatment Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Kidney Cancer Treatment Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Kidney Cancer Treatment Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Kidney Cancer Treatment Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Kidney Cancer Treatment Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Amgen/Allergan Company Information

Table 71. Amgen/Allergan Description and Business Overview

Table 72. Amgen/Allergan Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Amgen/Allergan Kidney Cancer Treatment Drugs Product

Table 74. Amgen/Allergan Recent Developments/Updates

Table 75. Argos Therapeutics Company Information

Table 76. Argos Therapeutics Description and Business Overview

Table 77. Argos Therapeutics Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Argos Therapeutics Kidney Cancer Treatment Drugs Product

Table 79. Argos Therapeutics Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. AstraZeneca Kidney Cancer Treatment Drugs Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Aveo Pharmaceuticals Company Information

Table 86. Aveo Pharmaceuticals Description and Business Overview

Table 87. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product

Table 89. Aveo Pharmaceuticals Recent Developments/Updates

Table 90. Bayer Company Information

Table 91. Bayer Description and Business Overview

Table 92. Bayer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Bayer Kidney Cancer Treatment Drugs Product

Table 94. Bayer Recent Developments/Updates

Table 95. Exelixis Company Information

Table 96. Exelixis Description and Business Overview

Table 97. Exelixis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Exelixis Kidney Cancer Treatment Drugs Product

Table 99. Exelixis Recent Developments/Updates

Table 100. Incyte Company Information

Table 101. Incyte Description and Business Overview

Table 102. Incyte Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Incyte Kidney Cancer Treatment Drugs Product

Table 104. Incyte Recent Developments/Updates

Table 105. Merck Company Information

Table 106. Merck Description and Business Overview

Table 107. Merck Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Merck Kidney Cancer Treatment Drugs Product

Table 109. Merck Recent Developments/Updates

Table 110. Roche Company Information

Table 111. Roche Description and Business Overview

Table 112. Roche Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Roche Kidney Cancer Treatment Drugs Product

Table 114. Roche Recent Developments/Updates

Table 115. Pfizer Company Information

Table 116. Pfizer Description and Business Overview

Table 117. Pfizer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Pfizer Kidney Cancer Treatment Drugs Product

Table 119. Pfizer Recent Developments/Updates

Table 120. Bristol-Myers Squibb Company Information

Table 121. Bristol-Myers Squibb Description and Business Overview

Table 122. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product

Table 124. Bristol-Myers Squibb Recent Developments/Updates

Table 125. Eisai Company Information

Table 126. Eisai Description and Business Overview

Table 127. Eisai Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Eisai Kidney Cancer Treatment Drugs Product

Table 129. Eisai Recent Developments/Updates

Table 130. Prometheus Labs Company Information

Table 131. Prometheus Labs Description and Business Overview

Table 132. Prometheus Labs Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Prometheus Labs Kidney Cancer Treatment Drugs Product

Table 134. Prometheus Labs Recent Developments/Updates

Table 135. Novartis Company Information

Table 136. Novartis Description and Business Overview

Table 137. Novartis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Novartis Kidney Cancer Treatment Drugs Product

Table 139. Novartis Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Kidney Cancer Treatment Drugs Distributors List

Table 143. Kidney Cancer Treatment Drugs Customers List

Table 144. Kidney Cancer Treatment Drugs Market Trends

Table 145. Kidney Cancer Treatment Drugs Market Drivers

Table 146. Kidney Cancer Treatment Drugs Market Challenges

Table 147. Kidney Cancer Treatment Drugs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Kidney Cancer Treatment Drugs

Figure 2. Global Kidney Cancer Treatment Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Kidney Cancer Treatment Drugs Market Share by Type: 2024 & 2031

Figure 4. Angiogenesis Inhibitors Product Picture

Figure 5. mTOR Inhibitors Product Picture

Figure 6. Monoclonal Antibodies Product Picture

Figure 7. Cytokine Immunotherapy (IL-2) Product Picture

Figure 8. Global Kidney Cancer Treatment Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Kidney Cancer Treatment Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospitals

Figure 11. Research Institutes

Figure 12. Diagnostic Centers

Figure 13. Others

Figure 14. Global Kidney Cancer Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Kidney Cancer Treatment Drugs Market Size (2020-2031) & (US$ Million)

Figure 16. Global Kidney Cancer Treatment Drugs Sales (2020-2031) & (K Units)

Figure 17. Global Kidney Cancer Treatment Drugs Average Price (USD/Unit) & (2020-2031)

Figure 18. Kidney Cancer Treatment Drugs Report Years Considered

Figure 19. Kidney Cancer Treatment Drugs Sales Share by Manufacturers in 2024

Figure 20. Global Kidney Cancer Treatment Drugs Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Kidney Cancer Treatment Drugs Players: Market Share by Revenue in Kidney Cancer Treatment Drugs in 2024

Figure 22. Kidney Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Kidney Cancer Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Kidney Cancer Treatment Drugs Sales Market Share by Country (2020-2031)

Figure 25. North America Kidney Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Kidney Cancer Treatment Drugs Sales Market Share by Country (2020-2031)

Figure 29. Europe Kidney Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)

Figure 30. Germany Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Kidney Cancer Treatment Drugs Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Kidney Cancer Treatment Drugs Revenue Market Share by Region (2020-2031)

Figure 37. China Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Kidney Cancer Treatment Drugs Sales Market Share by Country (2020-2031)

Figure 48. Latin America Kidney Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Kidney Cancer Treatment Drugs Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Kidney Cancer Treatment Drugs Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Kidney Cancer Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Kidney Cancer Treatment Drugs by Type (2020-2031)

Figure 58. Global Revenue Market Share of Kidney Cancer Treatment Drugs by Type (2020-2031)

Figure 59. Global Kidney Cancer Treatment Drugs Price (USD/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Kidney Cancer Treatment Drugs by Application (2020-2031)

Figure 61. Global Revenue Market Share of Kidney Cancer Treatment Drugs by Application (2020-2031)

Figure 62. Global Kidney Cancer Treatment Drugs Price (USD/Unit) by Application (2020-2031)

Figure 63. Kidney Cancer Treatment Drugs Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-1P20078

Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Breast Tissue Marker Clip Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-12T16952

Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Taxol Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-35W17004

Fri Nov 07 00:00:00 UTC 2025

Add to Cart

Global Medical Alpha Radionuclide Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-21U17036

Fri Nov 07 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Kidney Cancer Treatment Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-28W9748

Global Kidney Cancer Treatment Drugs Market Research Report 2025

FEATURED COMPANIES

Kidney Cancer Treatment Drugs Market Size

Kidney Cancer Treatment Drugs Market

Report Scope

Scope of Kidney Cancer Treatment Drugs Market Report

Core Chapters

FAQ for this report

How fast is Kidney Cancer Treatment Drugs Market growing?

What is the Kidney Cancer Treatment Drugs Market size in 2031?

Who are the main players in the Kidney Cancer Treatment Drugs Market report?

What are the Application segmentation covered in the Kidney Cancer Treatment Drugs Market report?

What are the Type segmentation covered in the Kidney Cancer Treatment Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS